NOVOS
NOVOS is a New York-based longevity biotech company selling multi-ingredient nutraceutical supplements targeting the 12 Hallmarks of Aging, a biological age test, and digital longevity tools to health-conscious consumers and 1,500+ clinicians across 180 countries.
- Company typePrivate
- Founded2019
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What NOVOS does
NOVOS is a New York-based longevity biotech company founded by Chris Mirabile in 2019 that develops and sells multi-ingredient nutraceutical formulations designed to address the 12 biological Hallmarks of Aging simultaneously. Its product portfolio spans NOVOS Core (an all-in-one longevity supplement containing 12 research-backed ingredients, the first formulation positioned to target all 12 Hallmarks in a single system), NOVOS Boost (NAD+/NMN support), NOVOS Vital (organ-support gummies), NOVOS Bar (a functional longevity nutrition bar co-developed with a Michelin-star pastry chef), and NOVOS Age (an at-home epigenetic biological age test using DunedinPACE and Yale Organ Age algorithms). The formulations are developed with a scientific team including Dr. George Church (Harvard/MIT), Dr. Pamela Maher (Salk Institute), Dr. J. Pedro Magalhães (Harvard, creator of the DrugAge database), and Dr. Robert Lufkin (USC), with Dr. Diogo Barardo (DrugAge creator) as Head of R&D.
The company's scientific differentiation rests on published evidence uncommon in the supplement category: an 18% lifespan extension in 20-month-old mice at Newcastle University; a randomized, double-blind, placebo-controlled human trial at the University of Surrey showing measurable improvements in vascular aging biomarkers (FMD +3.4%, PWV -1.18 m/s, SBP -8.5 mmHg vs. placebo); and in-vitro evidence of up to 77% reduction in DNA oxidative damage and ~50% reduction in senescent cell size. Patents on the Core formulation were filed in 2020.
NOVOS operates a primarily direct-to-consumer e-commerce model at Novoslabs.com (subscription and one-time purchase, ships to 180 countries) supplemented by premium retail distribution through Mayo Clinic Store, Erewhon, Equinox, Four Seasons, Bumrungrad International Hospital, and Sunlife Organics, plus a digital ecosystem (NOVOS Life app, NOVOS FaceAge AI tool, NOVOS Flow blog, longevity diet and regimen content). Customers include health-conscious individual consumers, biohackers, 1,500+ recommending clinicians, and longevity-medicine practices. The company is structured as a Public Benefit Corporation and in March 2025 received a minority investment from Unilever Ventures.
NOVOS firmographics
Firmographics- Name
- NOVOS
- Legal name
- NOVOS Labs
- Website
- https://novoslabs.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NOVOS is a New York-based longevity biotech company selling multi-ingredient nutraceutical supplements targeting the 12 Hallmarks of Aging, a biological age test, and digital longevity tools to health-conscious consumers and 1,500+ clinicians across 180 countries.
- Ownership category
- akta.pro rank
NOVOS industry classification
Industry- Product category
- Longevity Supplements
- NAICS
- Food (Health) Supplement Retailers (456191), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Healthy Aging & Cognitive Support Supplements (CRADAGAM)
- akta.pro secondary industries
- Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)
Keywords
Where NOVOS is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Markets served
NOVOS business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Direct-to-Consumer Supplement Sales: NOVOS generates revenue primarily through direct online sales of its longevity supplement products (NOVOS Core, Bar, Vital, Boost, Age) via subscription and one-time purchase models through its e-commerce storefront at Novoslabs.com. Subscription plans offer discounts of 10-27% off monthly pricing. The company ships to 180 countries internationally.
- Retail and Clinic Distribution: Products are available through select retail partners including Mayo Clinic Store, Erewhon, Equinox Four Seasons, and Sunlife Organics, providing revenue through wholesale/distributor arrangements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | NOVOS Core — All-In-One Longevity Foundation |
| Subscription | Monthly | NOVOS Boost — NAD+ / NMN Support |
| Subscription | Monthly | NOVOS Vital — Organ Support Gummies |
| Subscription | Monthly | NOVOS Bar — Longevity Nutrition Bar |
| One time/ perpetual license | Pay-as-you-go | NOVOS Age — Biological Age Test |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels9 records
NOVOS product offering
Product offeringCore offering
NOVOS develops, manufactures, and sells science-based nutraceutical supplements and a biological age test kit targeting the biological causes of aging. Its flagship product, NOVOS Core, is an all-in-one daily formulation designed to address all 12 biological Hallmarks of Aging simultaneously, complemented by NOVOS Bar (longevity nutrition bar), NOVOS Vital (organ support gummies), NOVOS Boost (NMN/NAD+ capsules), and NOVOS Age (at-home epigenetic biological age test). The portfolio is sold primarily direct-to-consumer via Novoslabs.com with subscription and one-time purchase options, distributed internationally to 180 countries.
Product overview
NOVOS is a longevity biotech company offering a portfolio of science-based nutraceutical products designed to target the biological causes of aging. The core product offering consists of NOVOS Core (an all-in-one daily longevity supplement drink addressing all 12 Hallmarks of Aging), NOVOS Bar (the first longevity nutrition bar with up to 20 superfoods), and NOVOS Age (an epigenetic biological age test). These are complemented by NOVOS Vital (targeted organ support gummies) and NOVOS Boost (NAD+ support with NMN). The products are developed with scientists from Harvard, MIT, Salk Institute, and other leading institutions, and are backed by clinical research including randomized placebo-controlled human trials. The company also provides complementary digital tools including the NOVOS Life app, NOVOS FaceAge facial age analysis, NOVOS Diet, and NOVOS Regimen protocols.
Differentiator
Problem solved
Functional benefit
Brands
- NOVOS Core: All-in-one longevity supplement formulated to address all 12 biological hallmarks of aging, clinically studied in randomized placebo-controlled human trials.
- NOVOS Boost
- NOVOS Bar
- NOVOS Vital
- NOVOS Age
- NOVOS Life
- NOVOS FaceAge
Products and services
- NOVOS Core The flagship all-in-one longevity supplement drink formulated to address all 12 biological Hallmarks of Aging in a single coordinated system. Backed by 7+ years of R&D and a randomized, placebo-controlled human clinical trial demonstrating positive results on cardiovascular aging markers. Contains 12 research-backed longevity ingredients including Calcium Alpha-Ketoglutarate, Fisetin, Pterostilbene, Glucosamine Sulfate, Glycine, Magnesium Malate, L-Theanine, Rhodiola Rosea, Gingerols, Hyaluronic Acid, Vitamin C, and Micro-dosed Lithium. Available as a monthly subscription ($98/box) or one-time purchase ($109/box) in Orange, Tropical Passion, or Unflavored.
- NOVOS Bar The first and only daily longevity nutrition bar, developed with longevity scientists, a registered dietitian, and a former Michelin Three-Star pastry chef. Contains up to 20 superfoods, 5 targeted longevity compounds (taurine, astaxanthin, and functional mushrooms including Lion's Mane, Reishi, Cordyceps), and 21 essential vitamins and minerals from natural food sources. Available in three flavors: Salted Chocolate Crunch, Mixed Berry Crunch, and Peanut Butter Chocolate Chip Crunch. Priced at $48/box (12 bars).
- NOVOS Vital Tropical-flavored gummy supplement formulated to optimize 7 vital organs (brain, heart, gut, eyes, liver, kidneys, and muscle). Contains 7 research-backed ingredients including Trehalose, Acetic Acid from ACV, Nattokinase, Lutein, Zeaxanthin, Rutin, and Inulin. Designed as targeted organ support to complement NOVOS Core. Available as a monthly subscription ($62/pouch) or one-time purchase ($69/pouch); each pouch contains 120 gummies (30-day supply at 4 gummies/day).
- NOVOS Boost NAD+ support formula containing 250mg of high-purity NMN (>99%) to support cellular energy production, metabolic health, and DNA maintenance. Targets 7 of the 12 biological causes of aging. Designed to be taken alongside NOVOS Core for comprehensive longevity support. Available as a monthly subscription ($39.50/bottle) or one-time purchase ($44/bottle); each bottle is a 30-day supply at a standard 2-capsule daily dose.
- NOVOS Age At-home biological age test kit using DNA methylation-based epigenetic algorithms (DunedinPACE from Columbia & Duke, and Organ Age from Yale) to measure biological age, organ system ages, and pace of aging. Provides baseline measurements and tracks improvements over time. Priced at $299 per kit; currently only available in the United States.
Quantifiable outcome
- 18% lifespan extension in aged mice (p=0.045, +127 days of life), outperforming any supplement in DrugAge database
- +11 more outcomes
Companies that use NOVOS
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
NOVOS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
NOVOS partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- Mayo Clinic StorecoreNOVOS products are available at the Mayo Clinic Store and recommended by Mayo Clinic physicians. Dr. Doina Kulick, Lead Physician of the Longevity Medicine Program at Mayo Clinic Arizona, has endorsed NOVOS's biology-first scientific approach. This partnership provides medical credibility and access to Mayo Clinic's patient population seeking clinically validated longevity interventions.
- ErewhoncorePremium wellness grocery retailer Erewhon carries NOVOS products in-store, providing physical retail distribution to health-conscious consumers in the premium wellness segment. Erewhon's brand alignment with health, wellness, and longevity makes it a strategic retail partner for NOVOS.
- EquinoxminorPremium fitness club chain Equinox offers NOVOS products to its members, targeting the intersection of fitness enthusiasts and longevity-focused consumers within Equinox's high-income member base.
- Dr. George Church (Harvard Medical School & MIT)coreScientific advisory board member and advisor. Dr. Church is a renowned genetics professor at Harvard Medical School and MIT. He provides research guidance and validation for NOVOS's multi-pathway approach to longevity, publicly stating: 'I see NOVOS as inspiring — they approach aging as a complex phenomenon, aiming at all pathways and hallmarks of aging simultaneously.'
- Dr. Pamela Maher (Salk Institute & University of British Columbia)coreScientific advisory board member and researcher. Dr. Maher contributed to the development of NOVOS Core through her research expertise in cellular aging and neurobiology at the Salk Institute for Biological Studies and the University of British Columbia.
- Dr. J. Pedro Magalhães (Harvard Medical School)coreScientific advisory board member and collaborator. Dr. Magalhães, formerly of Harvard Medical School, is known for building the DrugAge database of lifespan studies. He has endorsed NOVOS as 'a leader in the longevity space' with a 'novel science-based approach' to formulation development.
- Dr. Robert Lufkin (USC School of Medicine)coreScientific advisory board member and professor at USC Keck School of Medicine. Dr. Lufkin provides validation for NOVOS's science-backed formulations, stating: 'It's the rigorously-researched, science-backed formulations that set NOVOS apart in the longevity supplements space.'
- Dr. Thomas von Zglinicki (Newcastle University)coreLed the preclinical lifespan study at Newcastle University's Biosciences Institute, examining NOVOS Core's effects on lifespan and healthspan in aged mice. Professor of Cellular Gerontology with over 43,000 citations. Study found 18% lifespan extension in aged mice receiving NOVOS Core vs. controls.
- Dr. Satomi Miwa (Newcastle University)coreCollaborated on the aged mouse lifespan study at Newcastle University's Biosciences Institute. Lecturer on the Translational Biology of Aging with over 10,000 citations. Dr. Miwa noted that the study 'demonstrates that this multi-ingredient formulation exhibits synergistic effects rarely achieved by a nutritional supplement.'
- Dr. Christian Heiss (University of Surrey)coreSenior author of the NOVOS Core double-blind, placebo-controlled human clinical trial conducted at the University of Surrey. Professor of Cardiovascular Medicine evaluated vascular aging biomarkers including FMD, PWV, and blood pressure in healthy adults aged 40+ over 6 months. Described the trial as providing 'rare human evidence that a multi-pathway nutritional strategy can meaningfully influence vascular aging biology.'
- Ichor Life SciencesminorIndependent third-party US-based laboratory specializing in DNA damage, cellular senescence, and aging research. Conducted studies demonstrating that NOVOS formulations protect against DNA damage (up to 77% reduction in 8-OHdG levels) in irradiated human endothelial cells.
- Bumrungrad International HospitalminorBumrungrad International Hospital, ranked among Newsweek's Top 100 Global Hospitals, carries NOVOS products, providing international medical credibility and distribution to patients in Southeast Asia and globally.
- Brooke Alpert (M.S., R.D., C.D.N.)coreRegistered dietitian and best-selling author collaborated on the NOVOS Bar formulation, providing nutritional expertise to ensure the bar's ingredient panel was both scientifically backed and nutritionally excellent, not sacrificing either side.
- Van Nguyen (former pastry chef, The French Laundry & Per Se)coreFormer Michelin Three-Star pastry chef at The French Laundry and Per Se collaborated on the NOVOS Bar formulation to ensure that taste was not an afterthought — creating something genuinely desirable rather than merely nutritionally compliant. Led product development for flavor and texture optimization.
- Dr. Diogo Barardo (NOVOS Head of R&D, National University of Singapore)coreNOVOS Head of Research & Development, PhD from the National University of Singapore, who previously built the world's largest aging research database (DrugAge). Applied DrugAge data to select longevity compounds for the NOVOS Bar formulation based on scientific evidence.
Scale indicators8 records
Recent moves6 records
Expansion highlights7 records
NOVOS competitors and assessment
Company assessmentDirect peers
- Elysium Health: Elysium Health is a direct competitor in the science-led longevity supplement category, founded by Harvard/MIT scientists (including Dr. Leonard Guarente) and best known for Basis (NAD+ precursor formulation). Closely comparable to NOVOS in scientific positioning, target customer (affluent health-conscious adults), and direct-to-consumer model, though Elysium's ingredient story is narrower (NAD+ pathway) versus NOVOS's 12-Hallmarks approach.
- Tally Health: Tally Health offers biological age testing (TallyAge™) paired with longevity supplements, directly overlapping NOVOS's combination of epigenetic testing (NOVOS Age) and supplement formulations. Targets a similar affluent, health-optimization consumer and operates a comparable DTC subscription model.
- Life Extension: Life Extension is one of the largest and longest-running direct-to-consumer supplement brands focused on longevity and healthy aging, offering a broad catalog of evidence-based formulations including NAD+ precursors, fisetin, and cellular health compounds that directly overlap with NOVOS Core and NOVOS Boost. Significantly larger and more established than NOVOS.
- Tru Niagen (ChromaDex): Tru Niagen is the consumer brand for Niagen (nicotinamide riboside), a leading NAD+ precursor supplement. Directly competes with NOVOS Boost (NMN-based NAD+ support) for the same cellular energy and longevity positioning, with strong retail distribution including Amazon and major drugstores.
- InsideTracker: InsideTracker offers biomarker testing combined with personalized supplement and longevity recommendations, overlapping NOVOS's NOVOS Age testing and NOVOS Core formulation strategy. Targets a similar performance- and longevity-focused consumer with a science-led, DTC subscription model.
- Blueprint (Bryan Johnson): Blueprint is Bryan Johnson's longevity-focused supplement and protocol brand, competing directly in the premium science-led longevity space with a multi-product stack. Notable for strong founder-led brand identity and aggressive longevity claims, overlapping NOVOS's positioning and target demographic.
- Momentous: Momentous offers science-led supplements targeted at high-performance and longevity consumers, with third-party testing and athlete endorsements. Comparable to NOVOS in scientific credibility, premium DTC positioning, and target customer (affluent health-optimizers, longevity-focused individuals).
Broad incumbents
- AG1 (Athletic Greens): AG1 is the leading premium daily greens/nutrition supplement, with a similar DTC subscription model, premium pricing, content-driven marketing strategy, and target consumer (affluent health-optimizers). While not specifically focused on longevity hallmarks, it occupies overlapping premium shelf space and competes for the same consumer budget allocation as NOVOS Core.
Emerging players
- DoNotAge: DoNotAge is an emerging longevity supplement brand with a science-led positioning comparable to NOVOS, offering supplements targeting hallmarks of aging (telomere support, senolytics, NAD+ precursors). Smaller and more niche than NOVOS, with less developed clinical evidence and distribution.
Regional players
- Jinfiniti (Yale-licensed epigenetic testing): Jinfiniti offers epigenetic age testing using the DunedinPACE algorithm (the same underlying science as NOVOS Age), making it a direct partial competitor in the biological age testing category. More focused on the testing/diagnostics side than supplement formulation, but overlaps with NOVOS Age for longevity-conscious consumers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
NOVOS social profiles
Digital presenceNOVOS financial estimates
Financial estimateRevenue estimate
Valuation estimate
NOVOS leadership team
Management profileNumber of profiles
Profiles2 records
NOVOS funding detail
Funding detailFunding overview
Funding rounds3 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NOVOS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NOVOS
What does NOVOS do?
NOVOS develops, manufactures, and sells science-based nutraceutical supplements and a biological age test kit targeting the biological causes of aging. Its flagship product, NOVOS Core, is an all-in-one daily formulation designed to address all 12 biological Hallmarks of Aging simultaneously, complemented by NOVOS Bar (longevity nutrition bar), NOVOS Vital (organ support gummies), NOVOS Boost (NMN/NAD+ capsules), and NOVOS Age (at-home epigenetic biological age test). The portfolio is sold primarily direct-to-consumer via Novoslabs.com with subscription and one-time purchase options, distributed internationally to 180 countries.
Is NOVOS a public or private company?
NOVOS is a private company. It is classified as venture growth investor backed and is currently operating.
When was NOVOS founded?
NOVOS was founded in 2019. It employs 11 to 50 people.
Where is NOVOS based?
NOVOS is headquartered in New York, United States, in the North America region.
How does NOVOS make money?
Two revenue lines are on record. Direct-to-Consumer Supplement Sales are the primary driver. The others are retail and Clinic Distribution.
Who are NOVOS's main competitors?
Direct peers on record are Elysium Health, Tally Health, Life Extension, Tru Niagen (ChromaDex), InsideTracker, Blueprint (Bryan Johnson) and Momentous. AG1 (Athletic Greens) is listed as a broad incumbent. DoNotAge is listed as an emerging player. Jinfiniti (Yale-licensed epigenetic testing) is listed as a regional player.
Does NOVOS have an API?
No public API is recorded for NOVOS.
What industry is NOVOS in?
NOVOS's product category is Longevity Supplements. Its primary akta.pro industry code is CRADAGAM, Healthy Aging & Cognitive Support Supplements, with a secondary code of AFAJAKAK, Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin). Its NAICS code is 456191 and its SIC code is 2833.